New Alzheimer's therapies have reached the clinic, but not the countryside

EURACTIV - Austria provisionally reimburses the new anti-amyloid Alzheimer's therapies, disease-modifying antibodies such as lecanemab and donanemab – and runs treatment centres in every province. On paper, it is a model rollout. Read more

[Getty Images: Yuichiro Chino]